Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACON
Aclarion
$8.70
-4.4%
$7.65
$6.20
$3,499.51
$5.05M1.4117,336 shs57,502 shs
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
$0.68
$0.77
$0.01
$6.59
$2.98M-0.159,934 shs10 shs
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
$5.16
-0.6%
$5.40
$2.01
$15.60
$9.27M5.2974,557 shs26,195 shs
Kindly MD, Inc. stock logo
KDLY
Kindly MD
$0.80
+1.3%
$5.03
$0.65
$34.77
$4.82MN/A2.29 million shs33.90 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACON
Aclarion
+1.68%+2.13%+17.04%+22.81%-99.40%
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
0.00%0.00%0.00%-34.47%-88.26%
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
+2.77%-6.15%+3.39%-21.72%+33.42%
Kindly MD, Inc. stock logo
KDLY
Kindly MD
-7.79%-22.58%-71.59%-93.08%-36.31%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACON
Aclarion
$8.70
-4.4%
$7.65
$6.20
$3,499.51
$5.05M1.4117,336 shs57,502 shs
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
$0.68
$0.77
$0.01
$6.59
$2.98M-0.159,934 shs10 shs
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
$5.16
-0.6%
$5.40
$2.01
$15.60
$9.27M5.2974,557 shs26,195 shs
Kindly MD, Inc. stock logo
KDLY
Kindly MD
$0.80
+1.3%
$5.03
$0.65
$34.77
$4.82MN/A2.29 million shs33.90 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACON
Aclarion
+1.68%+2.13%+17.04%+22.81%-99.40%
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
0.00%0.00%0.00%-34.47%-88.26%
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
+2.77%-6.15%+3.39%-21.72%+33.42%
Kindly MD, Inc. stock logo
KDLY
Kindly MD
-7.79%-22.58%-71.59%-93.08%-36.31%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aclarion, Inc. stock logo
ACON
Aclarion
1.50
Reduce$11,758.50135,055.17% Upside
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
0.00
N/AN/AN/A
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
1.00
SellN/AN/A
Kindly MD, Inc. stock logo
KDLY
Kindly MD
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ATIP, BGLC, ACON, and KDLY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
Aclarion, Inc. stock logo
ACON
Aclarion
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/8/2025
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Aclarion, Inc. stock logo
ACON
Aclarion
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/27/2025
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 10/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aclarion, Inc. stock logo
ACON
Aclarion
$50K100.92N/AN/A$51.50 per share0.17
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
$741.86M0.00$3.55 per share0.19($23.96) per share-0.03
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
$9.55M0.97N/AN/A$4.63 per share1.11
Kindly MD, Inc. stock logo
KDLY
Kindly MD
$2.47M1.95N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aclarion, Inc. stock logo
ACON
Aclarion
-$6.99MN/A0.00N/AN/A-11,238.59%-83.63%-76.55%11/13/2025 (Estimated)
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
-$69.79M-$19.42N/AN/A-7.79%N/A-3.87%11/3/2025 (Estimated)
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
-$1.60MN/A0.00N/A-30.70%-35.54%-29.08%N/A
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A-$0.77N/AN/AN/AN/AN/AN/A

Latest ATIP, BGLC, ACON, and KDLY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/13/2025Q3 2025
Aclarion, Inc. stock logo
ACON
Aclarion
-$2.64N/AN/AN/AN/AN/A
8/18/2025Q2 2025
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
N/A-$0.34N/A-$0.34N/A$2.26 million
8/14/2025Q2 2025
Aclarion, Inc. stock logo
ACON
Aclarion
-$2.26-$2.75-$0.49-$2.75$0.03 million$0.02 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aclarion, Inc. stock logo
ACON
Aclarion
N/AN/AN/AN/AN/A
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
N/AN/AN/AN/AN/A
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
N/AN/AN/AN/AN/A
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aclarion, Inc. stock logo
ACON
Aclarion
N/A
23.83
23.83
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
N/A
1.12
1.12
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
N/A
3.63
2.94
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A
5.43
5.42

Institutional Ownership

CompanyInstitutional Ownership
Aclarion, Inc. stock logo
ACON
Aclarion
7.52%
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
72.60%
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
18.85%
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A

Insider Ownership

CompanyInsider Ownership
Aclarion, Inc. stock logo
ACON
Aclarion
0.77%
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
3.30%
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
0.70%
Kindly MD, Inc. stock logo
KDLY
Kindly MD
50.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aclarion, Inc. stock logo
ACON
Aclarion
7580,000578,000Not Optionable
ATI Physical Therapy, Inc. stock logo
ATIP
ATI Physical Therapy
5,6004.41 million4.27 millionNo Data
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
301.80 million1.78 millionNot Optionable
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A6.02 million2.96 millionN/A

Recent News About These Companies

NAKA Kindly MD, Inc.
Kindly MD Changes Ticker Symbols Amid Merger
KindlyMD shareholders approve Nakamoto merger
Target, Astera Labs, Kindly MD: Trending Tickers

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aclarion stock logo

Aclarion NASDAQ:ACON

$8.70 -0.40 (-4.40%)
Closing price 04:00 PM Eastern
Extended Trading
$8.76 +0.06 (+0.70%)
As of 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

ATI Physical Therapy stock logo

ATI Physical Therapy NYSE:ATIP

ATI Physical Therapy, Inc. operates as an outpatient physical therapy provider that specializes in outpatient rehabilitation and adjacent healthcare services in the United States. It offers a range of services to its patients, including physical therapy to treat spine, shoulder, knee, and neck injuries or pain; work injury rehabilitation services, work conditioning and work hardening; and hand therapy, aquatic therapy, functional capacity evaluation, sports medicine, and wellness programs. It also provides ATI worksite solutions comprising injury prevention programs, work-related injury assessment services, wellness offerings, and consultations for employers; proprietary electronic medical records (EMR) integration, caseload management, and continuing education in therapy treatments; and sports medicine, including on-site sports physical therapy, clinical evaluation and diagnosis, immediate and emergency care, nutrition programs, and concussion management services. The company offers outpatient physical therapy services under the ATI brand name. ATI Physical Therapy, Inc. was founded in 1996 and is based in Bolingbrook, Illinois.

BioNexus Gene Lab stock logo

BioNexus Gene Lab NASDAQ:BGLC

$5.16 -0.03 (-0.58%)
Closing price 03:59 PM Eastern
Extended Trading
$5.14 -0.02 (-0.39%)
As of 07:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Kindly MD stock logo

Kindly MD NASDAQ:KDLY

$0.80 +0.01 (+1.29%)
As of 10/15/2025

Kindly MD, Inc. provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. The company was founded by Timothy Pickett in December 2019 and is headquartered in Murray, UT.